IRIS UniCatt

Basso, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.942
EU - Europa 1.584
AS - Asia 611
SA - Sud America 89
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.926
DE - Germania 625
SE - Svezia 300
CN - Cina 227
SG - Singapore 205
IT - Italia 200
BR - Brasile 78
FR - Francia 76
UA - Ucraina 69
IE - Irlanda 59
GB - Regno Unito 58
FI - Finlandia 57
IN - India 51
ID - Indonesia 40
RU - Federazione Russa 40
PL - Polonia 24
CI - Costa d'Avorio 22
BE - Belgio 21
TR - Turchia 21
IR - Iran 13
AT - Austria 9
CA - Canada 9
HK - Hong Kong 9
NL - Olanda 9
VN - Vietnam 9
CZ - Repubblica Ceca 6
GR - Grecia 6
KR - Corea 6
AR - Argentina 5
LT - Lituania 5
BD - Bangladesh 4
IQ - Iraq 4
JP - Giappone 4
MX - Messico 4
PK - Pakistan 4
RO - Romania 4
EC - Ecuador 3
AU - Australia 2
CH - Svizzera 2
DK - Danimarca 2
ES - Italia 2
EU - Europa 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
BN - Brunei Darussalam 1
CL - Cile 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
ZA - Sudafrica 1
Totale 4.255
Salva come PNG Salva come JPEG
Città #
Ashburn 566
Chandler 320
Singapore 134
Dublin 58
Ann Arbor 52
San Mateo 52
Wilmington 52
Cattolica 45
New York 44
Jacksonville 42
Nanjing 41
Rome 41
Jakarta 39
Helsinki 38
The Dalles 34
Nürnberg 33
Boston 30
Dearborn 29
Woodbridge 28
Chicago 27
Fairfield 26
Moscow 25
Princeton 25
Abidjan 22
Warsaw 22
Los Angeles 21
Milan 21
Munich 21
Nanchang 21
Brussels 20
Marseille 20
Hyderabad 19
Redwood City 19
Izmir 17
Boardman 16
Beijing 15
Houston 15
Seattle 15
Shanghai 15
Frankfurt am Main 14
Redmond 14
Bremen 13
Augusta 12
Falls Church 12
Hangzhou 12
Changsha 11
Lawrence 10
Leawood 10
Hebei 9
Mountain View 9
Norwalk 9
Cambridge 8
Santa Clara 8
Zhengzhou 7
Guangzhou 6
London 6
Nuremberg 6
Bari 5
Fremont 5
Hong Kong 5
Kunming 5
São Paulo 5
Toronto 5
Washington 5
Andover 4
Athens 4
Brno 4
Düsseldorf 4
Falkenstein 4
Hefei 4
Jiaxing 4
Kish 4
Lanzhou 4
Newark 4
Plainfield 4
Seoul 4
Shenyang 4
Vienna 4
Amsterdam 3
Bexley 3
Detroit 3
Hanoi 3
Jinan 3
Mexico City 3
Miami 3
Northbrook 3
Piacenza 3
Portsmouth 3
San Diego 3
San Francisco 3
Stockholm 3
University Park 3
Bangkok 2
Birmingham 2
Bishkek 2
Brooklyn 2
Changchun 2
Council Bluffs 2
Curitiba 2
Florence 2
Totale 2.405
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 527
A phase II study of sunitinib in advanced hepatocellular carcinoma 217
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 216
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 190
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 169
Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study 155
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 139
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 139
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 138
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 119
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 116
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 111
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 110
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 98
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 93
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 92
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 91
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 88
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 86
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 85
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 84
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 83
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 83
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 80
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 79
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 76
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 75
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 72
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 70
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 70
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 66
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 65
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 62
Operator learning curve for transradial liver cancer embolization: Implications for the initiation of a transradial access program 60
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 58
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 52
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 45
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 43
New life for retrospective study in the precision oncology era 42
Targeted therapy in advanced gastric carcinoma: The future is beginning 32
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 24
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 22
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 6
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 4
Totale 4.332
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 0 0 0 0 0 0 0 36
2020/2021267 8 37 38 16 30 12 26 4 25 27 38 6
2021/2022451 37 16 12 64 27 11 7 68 17 37 60 95
2022/2023873 123 118 70 160 30 98 48 74 74 25 32 21
2023/2024855 19 89 28 14 11 71 234 263 2 16 38 70
2024/2025774 15 39 70 37 75 37 32 36 92 93 165 83
Totale 4.332